Can atorvastatin (statin) cause frequent stools?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Atorvastatin and Frequent Stools

Atorvastatin does not commonly cause frequent stools, but mild gastrointestinal disturbances including diarrhea can occur in approximately 6.8% of patients taking the medication. 1, 2

Gastrointestinal Side Effects of Atorvastatin

The FDA-approved drug label for atorvastatin reports the following gastrointestinal side effects:

  • Diarrhea: 6.8% of patients (compared to 6.3% with placebo)
  • Dyspepsia: 4.7% of patients
  • Nausea: 4.0% of patients
  • Abdominal discomfort, eructation, and flatulence are also reported 1

The incidence of diarrhea appears to be dose-dependent, with higher rates observed at higher doses:

  • 7.3% at 10 mg
  • 6.4% at 20 mg
  • 14.1% at 40 mg
  • 5.2% at 80 mg 1

Mechanism of Action and GI Effects

Atorvastatin works by inhibiting HMG-CoA reductase, limiting cholesterol formation. Unlike bile acid sequestrants (such as colesevelam, cholestyramine, and colestipol) that are specifically known to cause constipation as a common side effect, atorvastatin does not directly target intestinal function or bile acid metabolism in a way that would predictably cause frequent stools 3.

Clinical Considerations

When evaluating a patient with frequent stools while on atorvastatin, consider:

  1. Temporal relationship: Did the symptoms begin after starting atorvastatin or after a dose increase?

  2. Rule out other causes:

    • Concurrent medications
    • Dietary changes
    • Underlying gastrointestinal conditions
  3. Management options if atorvastatin is suspected:

    • Consider dose reduction if clinically appropriate
    • Consider switching to another statin (pravastatin or fluvastatin) that may have different side effect profiles
    • Monitor liver function tests as elevated liver enzymes can occur in 0.7% of patients on atorvastatin 1

Clinical Evidence on Safety

A prospective study of 3,227 patients taking atorvastatin 40 mg daily found that only 1.2% reported gastrointestinal disturbances, and only 1.6% of all patients discontinued therapy due to any adverse effects 4. This suggests that while GI side effects can occur, they are generally well-tolerated and rarely lead to discontinuation.

Important Caveats

  • Paradoxical effects: In some specific patient populations, such as those with ulcerative colitis, atorvastatin may potentially worsen symptoms, including diarrhea 5

  • Drug interactions: Atorvastatin interactions with other medications may indirectly affect GI function. For example, when combined with cyclosporine or other immunosuppressants, there may be altered drug metabolism that could affect GI symptoms 3

  • Individual variation: Response to statins varies significantly between individuals, and some patients may be more sensitive to GI effects than others

Conclusion

While atorvastatin can cause diarrhea in a small percentage of patients, it is not specifically known for causing frequent stools as a primary side effect. If a patient develops this symptom while on atorvastatin, clinical evaluation should determine if the medication is the cause or if other factors are contributing to the symptoms.

References

Research

Atorvastatin: a hydroxymethylglutaryl-coenzyme A reductase inhibitor.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Randomized clinical trial: atorvastatin versus placebo in patients with acute exacerbation of mild to moderate ulcerative colitis.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.